$1.54
0.053.36%
Last update: Nov 10, 9:09 AM
Zhengye Biotechnology Holding Ltd
ZYBTNASDAQ
Zhengye Biotechnology fell 29.7% from $2.12 to $1.49, behind the S&P 500's +9.8%. Its worst day was Jul 21 (−64.4%), and its low came Jul 2 at $0.65.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.06 was reported on $8.7M revenue.
−4.0% · S&P 500 −0.2%
EPS of $-0.21 was reported on $16.6M revenue.
−6.8% · S&P 500 0.0%
Story events cover the past 12 months · Times ET
Zhengye Biotechnology closed at its lowest level of the year, 69.5% below where the year started.
−4.5% · S&P 500 −0.1%
Zhengye Biotechnology closed at its highest level of the year, 277.8% above where the year started.
+1047.6%, the year's best day, on 166M shares, the year's heaviest volume · S&P 500 −0.2%
Where it ended: a close of $1.49 on Nov 9, 2026. Up next: H1 2026 earnings on Dec 11, 2026.
Nothing in the past 12 months.
All ZYBT analyst actionsNothing in the past 12 months.
All ZYBT dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ZYBT and SPY from Benzinga historical bars. Not investment advice.
